498 related articles for article (PubMed ID: 28766228)
1. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
3. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
Jia M; Pan L; Yang H; Gao J; Guo F
Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
5. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer related lymphedema in patients with different loco-regional treatments.
Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
[TBL] [Abstract][Full Text] [Related]
7. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
Bucci LK; Brunelle CL; Bernstein MC; Shui AM; Gillespie TC; Roberts SA; Naoum GE; Taghian AG
Ann Surg Oncol; 2021 Dec; 28(13):8624-8633. PubMed ID: 34117574
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
11. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
13. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence.
Rochlin DH; Barrio AV; McLaughlin S; Van Zee KJ; Woods JF; Dayan JH; Coriddi MR; McGrath LA; Bloomfield EA; Boe L; Mehrara BJ
JAMA Surg; 2023 Sep; 158(9):954-964. PubMed ID: 37436762
[TBL] [Abstract][Full Text] [Related]
14. Periclavicular Lymph Node Activation Maintains the Lymphatic Circulation of Upper Extremity Following Breast Cancer Surgery with Axillary Lymph Node Dissection.
Kang SH; Lee DG
Lymphat Res Biol; 2021 Jun; 19(3):256-260. PubMed ID: 32986507
[No Abstract] [Full Text] [Related]
15. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
16. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
[TBL] [Abstract][Full Text] [Related]
17. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for lymphedema after breast cancer treatment.
Norman SA; Localio AR; Kallan MJ; Weber AL; Torpey HA; Potashnik SL; Miller LT; Fox KR; DeMichele A; Solin LJ
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2734-46. PubMed ID: 20978176
[TBL] [Abstract][Full Text] [Related]
19. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
[TBL] [Abstract][Full Text] [Related]
20. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
